UBS Knock-Out ABT/ DE000UL7G2L9 /
7/29/2024 3:50:57 PM | Chg.-0.36 | Bid4:28:15 PM | Ask4:28:15 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.53EUR | -19.05% | 1.50 Bid Size: 10,000 |
1.51 Ask Size: 10,000 |
Abbott Laboratories | 85.2253 USD | 12/31/2078 | Call |
GlobeNewswire
6/6
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors